hypothesis glutathione persister cells Mechanism of Drug Tolerant Cancer Cells: The Landscape and Clinical Implication for Therapy Low-GPX4 drives a sustained drug-tolerant
Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect JCI Insight Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition PMC Glutathione accelerates the cell cycle and cellular reprogramming in plant regeneration: Developmental Cell
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



